Co-Therapy of Silymarin and Vitamin E Attenuates Doxorubicin-Induced Hepatotoxicity in Rats by Mitigating Oxidative Damage and Preserving Hepatic Architecture. Tikrit J. Pharm. Sci. [Internet]. 2026 Jun. 30 [cited 2026 Aug. 8];20(1):20-32. Available from: https://tjphs.tu.edu.iq/index.php/j/article/view/689